NCT07421479 Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07260188 Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy Status RECRUITING Phase N/A
NCT06926543 Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy Status RECRUITING Phase PHASE3
NCT06677944 Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer Status RECRUITING Phase PHASE2
NCT06357338 Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma Status ENROLLING_BY_INVITATION Phase N/A
NCT06328465 fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases Status RECRUITING Phase NA
NCT06268665 Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Status RECRUITING Phase PHASE2
NCT06158217 Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer Status UNKNOWN Phase N/A
NCT05767931 Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer Status UNKNOWN Phase N/A
NCT05703815 EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast Status UNKNOWN Phase N/A
NCT05607004 (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer Status RECRUITING Phase PHASE2
NCT05412225 A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer Status RECRUITING Phase PHASE1
NCT05318274 Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04677816 Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients Status RECRUITING Phase PHASE2
NCT04648904 Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT04553770 Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer Status RECRUITING Phase PHASE2